Tetrastatin binds integrin alphaVbeta3

Stable Identifier
R-HSA-4088218
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Tetrastatin, the non-collagenous C-terminal domain of collagen alpha-4(IV) has anti-tumor activity in a human melanoma model, decreasing proliferative and invasive properties of melanoma cells. This effect is mediated by integrin alphaVBeta3.
Literature References
PubMed ID Title Journal Year
22539938 Tetrastatin, the NC1 domain of the ?4(IV) collagen chain: a novel potent anti-tumor matrikine

Brézillon, S, Di Stefano, L, Thevenard, J, Sénéchal, K, Devy, J, Jazeron, JF, Monboisse, JC, Brassart-Pasco, S, Feru, J, Ramont, L, Dupont-Deshorgue, A, Maquart, FX, Diebold, MD, Ricard-Blum, S

PLoS ONE 2012
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!